Skip to main content
. 2022 May 1;2:100089. doi: 10.1016/j.crpvbd.2022.100089

Table 1.

Laboratory bioassay results for Bacillus thuringiensis var. israelensis (Bactivec®) and Bacillus sphaericus (Griselesf®) treatments against larvae of Anopheles gambiae complex, Culex quinquefasciatus and Aedes aegypti

Mosquito species (strain) Biolarvicide No. testeda LC50b (95% CI) LC95b (95% CI) Slope ± SE χ2 (df) Heterogeneityc
An. gambiae (s.s.) (laboratory) Bti 1800 0.023 (0.022–0.025) 0.063 (0.056–0.072) 3.814 ± 0.186 2.789 (3) 0.930
Bs 2100 0.029 (0.021–0.040) 0.086 (0.058–0.188) 3.491 ± 0.159 38.974 (4) 9.743
An. gambiae complex (wild) Bti 1800 0.029 (0.020–0.042) 0.096 (0.061–0.244) 3.167 ± 0.146 23.728 (3) 7.909
Bs 2100 0.022 (0.013–0.034) 0.071 (0.042–0.292) 3.204 ± 0.153 67.020 (4) 16.755
Cx. quinquefasciatus (laboratory) Bti 1800 0.026 (0.015–0.047) 0.106 (0.056–0.633) 2.709 ± 0.108 54.817 (3) 18.272
Bs 1800 0.017 (0.013–0.022) 0.040 (0.028–0.099) 4.386 ± 0.227 28.194 (3) 9.398
Cx. quinquefasciatus (wild) Bti 1800 0.028 (0.020–0.038) 0.123 (0.079–0.267) 2.548 ± 0.100 19.956 (3) 6.652
Bs 1800 0.021 (0.013–0.036) 0.054 (0.033–0.486) 3.980 ± 0.192 58.924 (3) 19.641
Ae. aegypti (laboratory) Bti 1800 0.018 (0.012–0.027) 0.052 (0.032–0.265) 3.545 ± 0.175 41.277 (3) 13.759
Ae. aegypti (wild) Bti 1800 0.037 (0.033–0.041) 0.099 (0.083–0.124) 3.859 ± 0.166 4.519 (3) 1.506

Abbreviations: Bti, Bacillus thuringiensis var. israelensis; Bs, Bacillus sphaericus; CI, confidence interval; SE, standard error; df, degrees of freedom.

a

1500 subjects and 300 controls in all tests except for Bs experiments with An. gambiae complex where there were 1800 subjects and 300 controls (control mortality did not exceed 4% in any experiment).

b

mg/litre at 24 and 48 h for Bti and Bs, respectively.

c

Definition: heterogeneity in the context of bioassay is the value of Chi-square divided by the degrees of freedom, a factor used to measure how well the values predicted by the model compared with the actual value observed in bioassay.